Authors:Subekti I, Laurentius A Pramono
Publication date: 2018 Apr
Acta Med Indones
Volume: 50 (2): 177-182
Link: http://www.actamedindones.org/index.php/ijim/article/view/817/pdf
ABSTRACT
Graves’ disease (GD) is an autoimmune disorder which affect thyroid gland. Graves’ disease is the most common cause of hyperthyroidism and thyrotoxicosis. Understanding of disease pathophysiology, diagnostic and treatment strategies, and prevention of disease relapse are important for all clinicians especially internal medicine specialist to give optimal and comprehensive management for GD patients. This article highlights clinical points to treat GD patients from reviews and latest guidelines from American Thyroid Association (ATA), European Thyroid Association (ETA), and Japan Thyroid Association/ Japan Endocrine Society.
Keywords: Graves’ disease, thyroid, American Thyroid Association (ATA), European Thyroid Association (ETA), Japan Thyroid Association/ Japan Endocrine Society.